Skip to main content
Log in

Curcumin protects mice against concanavalin A-induced hepatitis by inhibiting intrahepatic intercellular adhesion molecule-1 (ICAM-1) and CXCL10 expression

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

The effect of curcumin on liver injury caused by Concanavalin A (Con A) has not been carefully examined. This study was designed to evaluate the protective effect of curcumin on Con A-induced hepatitis in mice. Liver injured mice received curcumin by gavage at a dose of 200 mg/kg body weight before Con A intravenous administration. Curcumin was effective in reducing the elevated plasma levels of aminotransferases and the incidence of liver necrosis compared with Con A-injected control group. Enzyme-linked immunosorbent assay (ELISA) showed that curcumin suppressed proinflammatory cytokines such as tumor necrosis factor (TNF)-α, interferon (IFN)-γ, and interleukin (IL)-4 production in Con A-injected mice. The reduced severity of hepatitis in curcumin pretreated mice correlated with decrease in numbers of liver CD4+ T cells but not CD8+ T cells by immunohistochemical analysis. Furthermore, the expression levels of intercellular adhesion molecule-1 (ICAM-1) and the interferon-inducible chemokine CXCL10 in hepatic tissue were significantly decreased by curcumin pretreatment. In conclusion, curcumin pretreatment protects against T cell-mediated hepatitis in mice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Liaw YF, Lee CS, Tsai SL et al (1995) T-cell-mediated autologous hepatocytotoxicity in patients with chronic hepatitis C virus infection. Hepatology 22(5):1368–1373

    PubMed  CAS  Google Scholar 

  2. Ajuebor MN, Carey JA, Swain MG (2006) CCR5 in T cell-mediated liver diseases: what’s going on. J Immunol 177(4):2039–2045

    PubMed  CAS  Google Scholar 

  3. Hong F, Jaruga B, Kim WH et al (2002) Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS. J Clin Invest 110(10):1503–1513

    PubMed  CAS  Google Scholar 

  4. Tiegs G, Hentschel J, Wendel A (1992) A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest 90(1):196–203

    Article  PubMed  CAS  Google Scholar 

  5. Beldi G, Wu Y, Banz Y et al (2008) Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis. Hepatology 48(3):841–852

    Article  PubMed  CAS  Google Scholar 

  6. Tagawa Y, Sekikawa K, Iwakura Y (1997) Suppression of concanavalin A-induced hepatitis in IFN-gamma(−/−) mice, but not in TNF-alpha(−/−) mice: role for IFN-gamma in activating apoptosis of hepatocytes. J Immunol 159(3):1418–1428

    PubMed  CAS  Google Scholar 

  7. Wolf D, Hallmann R, Sass G et al (2001) TNF-alpha-induced expression of adhesion molecules in the liver is under the control of TNFR1—relevance for concanavalin A-induced hepatitis. J Immunol 166(2):1300–1307

    PubMed  CAS  Google Scholar 

  8. Lafdil F, Wang H, Park O et al (2009) Myeloid STAT3 inhibits T cell-mediated hepatitis by regulating T helper 1 cytokine and interleukin-17 production. Gastroenterology 137(6):2125–2126

    Article  PubMed  CAS  Google Scholar 

  9. Shetty S, Lalor PF, Adams DH (2008) Lymphocyte recruitment to the liver: molecular insights into the pathogenesis of liver injury and hepatitis. Toxicology 254(3):136–146

    Article  PubMed  CAS  Google Scholar 

  10. Ajuebor MN, Hogaboam CM, Le T, Proudfoot AE, Swain MG (2004) CCL3/MIP-1alpha is pro-inflammatory in murine T cell-mediated hepatitis by recruiting CCR1-expressing CD4(+) T cells to the liver. Eur J Immunol 34(10):2907–2918

    Article  PubMed  CAS  Google Scholar 

  11. Kawasuji A, Hasegawa M, Horikawa M et al (2006) L-selectin and intercellular adhesion molecule-1 regulate the development of concanavalin A-induced liver injury. J Leukoc Biol 79(4):696–705

    Article  PubMed  CAS  Google Scholar 

  12. Curbishley SM, Eksteen B, Gladue RP, Lalor P, Adams DH (2005) CXCR 3 activation promotes lymphocyte transendothelial migration across human hepatic endothelium under fluid flow. Am J Pathol 167(3):887–899

    Article  PubMed  CAS  Google Scholar 

  13. Corson TW, Crews CM (2007) Molecular understanding and modern application of traditional medicines: triumphs and trials. Cell 130(5):769–774

    Article  PubMed  CAS  Google Scholar 

  14. Aggarwal BB, Harikumar KB (2009) Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol 41(1):40–59

    Article  PubMed  CAS  Google Scholar 

  15. Tang Y, Zheng S, Chen A (2009) Curcumin eliminates leptin’s effects on hepatic stellate cell activation via interrupting leptin signaling. Endocrinology 150(7):3011–3020

    Article  PubMed  CAS  Google Scholar 

  16. Xie L, Li XK, Funeshima-Fuji N et al (2009) Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production. Int Immunopharmacol 9(5):575–581

    Article  PubMed  CAS  Google Scholar 

  17. Bozza M, Bliss JL, Maylor R et al (1999) Interleukin-11 reduces T-cell-dependent experimental liver injury in mice. Hepatology 30(6):1441–1447

    Article  PubMed  CAS  Google Scholar 

  18. Bonder CS, Norman MU, Swain MG et al (2005) Rules of recruitment for Th1 and Th2 lymphocytes in inflamed liver: a role for alpha-4 integrin and vascular adhesion protein-1. Immunity 23(2):153–163

    Article  PubMed  CAS  Google Scholar 

  19. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4):402–408

    Article  PubMed  CAS  Google Scholar 

  20. Siddiqui AM, Cui X, Wu R et al (2006) The anti-inflammatory effect of curcumin in an experimental model of sepsis is mediated by up-regulation of peroxisome proliferator-activated receptor-gamma. Crit Care Med 34(7):1874–1882

    Article  PubMed  CAS  Google Scholar 

  21. Fu Y, Zheng S, Lin J, Ryerse J, Chen A (2008) Curcumin protects the rat liver from CCl4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation. Mol Pharmacol 73(2):399–409

    Article  PubMed  CAS  Google Scholar 

  22. Oo YH, Adams DH (2010) The role of chemokines in the recruitment of lymphocytes to the liver. J Autoimmun 34(1):45–54

    Article  PubMed  CAS  Google Scholar 

  23. Kaneko Y, Harada M, Kawano T et al (2000) Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J Exp Med 191(1):105–114

    Article  PubMed  CAS  Google Scholar 

  24. Mizuhara H, O’Neill E, Seki N et al (1994) T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. J Exp Med 179(5):1529–1537

    Article  PubMed  CAS  Google Scholar 

  25. Sugimoto K, Hanai H, Tozawa K et al (2002) Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice. Gastroenterology 123(6):1912–1922

    Article  PubMed  CAS  Google Scholar 

  26. Park S, Murray D, John B, Crispe IN (2002) Biology and significance of T-cell apoptosis in the liver. Immunol Cell Biol 80(1):74–83

    Article  PubMed  Google Scholar 

  27. Scoazec JY, Feldmann G (1994) The cell adhesion molecules of hepatic sinusoidal endothelial cells. J Hepatol 20(2):296–300

    Article  PubMed  CAS  Google Scholar 

  28. Jaruga B, Hong F, Kim WH, Gao B (2004) IFN-gamma/STAT1 acts as a proinflammatory signal in T cell-mediated hepatitis via induction of multiple chemokines and adhesion molecules: a critical role of IRF-1. Am J Physiol Gastrointest Liver Physiol 287(5):G1044–G1052

    Article  PubMed  CAS  Google Scholar 

  29. Li X, Klintman D, Liu Q, Sato T, Jeppsson B, Thorlacius H (2004) Critical role of CXC chemokines in endotoxemic liver injury in mice. J Leukoc Biol 75(3):443–452

    Article  PubMed  CAS  Google Scholar 

  30. Simpson KJ, Henderson NC, Bone-Larson CL, Lukacs NW, Hogaboam CM, Kunkel SL (2003) Chemokines in the pathogenesis of liver disease: so many players with poorly defined roles. Clin Sci 104(1):47–63

    Article  PubMed  CAS  Google Scholar 

  31. Zeremski M, Petrovic LM, Chiriboga L et al (2008) Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C. Hepatology 48(5):1440–1450

    Article  PubMed  CAS  Google Scholar 

  32. Koniaris LG, Zimmers-Koniaris T, Hsiao EC, Chavin K, Sitzmann JV, Farber JM (2001) Cytokine-responsive gene-2/IFN-inducible protein-10 expression in multiple models of liver and bile duct injury suggests a role in tissue regeneration. J Immunol 167(1):399–406

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shun-cai Zhang.

Additional information

Chuan-tao Tu and Bing Han contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tu, Ct., Han, B., Liu, Hc. et al. Curcumin protects mice against concanavalin A-induced hepatitis by inhibiting intrahepatic intercellular adhesion molecule-1 (ICAM-1) and CXCL10 expression. Mol Cell Biochem 358, 53–60 (2011). https://doi.org/10.1007/s11010-011-0920-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-011-0920-4

Keywords

Navigation